Does intraperitoneal ropivacaine reduce postoperative inflammation? A prospective, double‐blind, placebo‐controlled pilot study

Autor:	Linda Block, Sven-Egron Thörn, Anil Gupta, Jane M. Hayden, Pontus Thulin, Jonatan Oras
Rok vydání:	2019
Předmět:	medicine.medical_treatment Pilot Projects Inflammation Placebo Proinflammatory cytokine 03 medical and health sciences Postoperative Complications 0302 clinical medicine Double-Blind Method Stress Physiological 030202 anesthesiology medicine Humans Ropivacaine Prospective Studies Anesthetics Local Saline Aged Ovarian Neoplasms business.industry Insulin 030208 emergency & critical care medicine General Medicine Perioperative Middle Aged Anesthesiology and Pain Medicine Anesthesia Cytokines Female medicine.symptom business Injections Intraperitoneal medicine.drug Abdominal surgery
Zdroj:	Acta Anaesthesiologica Scandinavica. 63:1048-1054
ISSN:	1399-6576 0001-5172
Popis:	Background Postoperative inflammation is a common consequence of surgery and the ensuing stress response. Local anesthetics have anti-inflammatory properties. The primary aim of this study was to evaluate if LA administrated intraperitoneally perioperatively might inhibit expression of inflammatory cytokines. Methods This was a, randomized, double blind, placebo-controlled study (ClinicalTrial.gov reg no: NCT02256228) in patients undergoing surgery for ovarian cancer. Patients were randomized to receive: intraperitoneal ropivacaine (Group IPLA) or saline (Group P) perioperatively. Except for study drug, patients were treated similarly. At the end of surgery, a multi-port catheter was inserted intraperitoneally, and ropivacaine 2 mg/mL or 0.9% saline, 10 mL was injected intermittently every other hour during 72 hours postoperatively. Systemic expression of cytokines and plasma ropivacaine were determined before and 6, 24, and 48 hours after surgery. Stress response was measured by serum glucose, cortisol, and insulin. Results Forty patients were recruited, 20 in each group. There was no statistical significant difference in systemic cytokine between the groups at any time point. Serum cortisol was significantly lower in the IPLA group at 6 hours, median 103 nmol/L (IQR 53-250) compared to placebo, median 440 nmol/L (IQR 115-885), P = 0.023. Serum glucose and insulin were similar between the groups. Total and free serum concentrations of ropivacaine were well below toxic concentrations. Conclusion In this small study, perioperative intraperitoneal ropivacaine did not reduce the systemic inflammatory response associated with major abdominal surgery. Total and free ropivacaine concentrations were below known toxic concentrations in humans.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309ee0d9e941024c3d9fe462cd997fa8 https://doi.org/10.1111/aas.13410 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.